Get Started →
FDA-Approved CLIA Certified HIPAA Compliant
Deep Learning · Precision Oncology

Precision oncology, powered by deep learning.

GenomixAI processes DNA sequencing data alongside millions of medical journals to identify mutations and match patients with targeted therapies and clinical trials — in hours, not weeks.

Get started Explore the Platform
98.7%
Variant detection accuracy
4.2hrs
Avg. turnaround time
12K+
Clinical trials indexed
SequencingSample #P-7842
ATCGGATCCAGT
CGATTCAGGCTA
GATCGTACTGAC
Whole-Genome SequencingAI Confidence 97.2%
Locus 01 — The Data Tsunami

Turning genomic data into life-saving insights

A single whole-genome sequence generates 200+ GB of data. We turn it into an answer.

The Challenge

Oncologists face a data tsunami. A single patient's whole-genome sequencing generates 200+ GB of data. Manually identifying actionable mutations against thousands of medical journals and clinical trials is nearly impossible.

The GenomixAI Solution

Our deep learning pipeline processes raw FASTQ files through a multi-layered neural network that identifies SNPs, indels, and fusion genes with 98.7% accuracy, then cross-references findings against 12,000+ clinical trials and 25M+ PubMed articles.

HIPAA Compliant
CLIA Certified
24-Hour Turnaround
🧬 DNA Sequencing
→
⚡ AI Mutation Calling
→
💊 Therapy Matching
Locus 02 — The Genomic Intelligence Stack

Four AI layers, one actionable insight

Purpose-built models that transform raw genomic data into oncology decisions.

Deep Variant Calling

Convolutional neural networks trained on 1M+ genomic samples detect SNPs, indels, and structural variants — reducing false positives by 62%.

CNN · WGS/WES

Knowledge Graph Mining

NLP and graph neural networks ingest 25M+ PubMed articles and 12K+ clinical trials to surface mutation-therapy associations.

GNN · NLP

Personalized Therapy Matching

AI ranks targeted therapies, immunotherapies and chemotherapies based on mutation profile, tumor type and treatment history.

Precision Oncology

Clinical Trial Matching

Automatically identifies active trials based on eligibility criteria, mutation profile and geographic location.

Trial Matching
Locus 03 — Live Pipeline

Patient #P-7842, AI confidence 97.2%

Live PipelinePatient #P-7842
DNA Seq
→
Variant Call
→
AI Analysis
→
Therapy Match
→
Trial Match
Analyzing 23,847 variants against 12.4M journal articles… 72%
Top Matches
Pembrolizumab
PD-L1 inhibitor · High response
94%
Nivolumab + Ipilimumab
Combination immunotherapy
89%
NCT04712994
Phase II · KRAS G12C
82%
NCT04548752
Phase III · EGFR exon 20
76%
Locus 04 — The Clinical Impact

Real outcomes from leading oncology centers

94%

Faster treatment initiation vs. manual genomic interpretation

3.2x

More patients matched to targeted therapies

62%

Reduction in false-positive variant calls

12K+

Clinical trials continuously monitored and indexed

"Every hour saved in treatment planning is a life that can be saved."

Locus 05 — Who We Serve

Built for precision medicine

GenomixAI empowers every stakeholder in the oncology care continuum.

Oncologists

Get actionable treatment recommendations backed by AI and the latest clinical evidence.

Geneticists & Pathologists

Accelerate variant interpretation with AI-powered annotation and filtering.

Academic Medical Centers

Integrate GenomixAI into your research workflows and clinical trials matching.

Pharmaceutical Companies

Accelerate patient recruitment for clinical trials with AI-powered matching.

Locus 06 — What Clinicians Say

Trusted by leading oncology centers worldwide

★★★★★
"GenomixAI identified a rare ALK fusion in a patient we were about to start on conventional chemotherapy. The AI matched them to a targeted therapy now showing a complete response."
Dr. Mitchell
Medical Oncologist, MD Anderson Cancer Center
★★★★★
"We went from 3 weeks to 48 hours for complete genomic reports. The AI's trial matching has tripled our patient enrollment in life-saving clinical trials."
Dr. James
Director of Genomics, Memorial Sloan Kettering
★★★★★
"The knowledge graph mining found a combination therapy from a 2024 publication that we had missed — it's now part of our standard protocol for EGFR-mutant lung cancer."
Dr. Ramon
Chief of Thoracic Oncology, Dana-Farber
Locus 07 — The Genomic Visionaries

AI researchers, oncologists and bioinformaticians

Dr. A

Dr. MARY OCHOLOGWA JAMES

CEO & Co-Founder

Oncologist turned AI entrepreneur. Former faculty at Johns Hopkins.

Dr. M

Dr. Faith Markcos

CTO & Co-Founder

AI/ML PhD with 5+ years in bioinformatics. Former Google Genomics.

Dr.

Dr. Richard Okilo

Head of Clinical Genomics

Board-certified geneticist. Former director of a CLIA-certified lab.

Dr. T

Dr. Ibrahim Hamza

VP of Research & Development

Computational biologist. Built the knowledge graph engine powering the platform.

Locus 08 — Get In Touch

Ready to transform cancer care?

Tell us about your practice or research, and we'll show you how GenomixAI can help.

Email
info@genomixai.com
24/7 Support
+234 9015705910
Address
High Level, Kanshio, Benue State
Urgent Clinical ConsultFor time-sensitive oncology cases, our team of board-certified geneticists is available for rapid consult. We prioritize life-saving cases.+234 9015705910
Locus 09 — Onboarding Sequence

Start saving lives with AI-powered genomics

Deploy GenomixAI in your practice or research lab in days, not months.

1

Upload

Securely upload FASTQ, BAM, or VCF files to our HIPAA-compliant cloud.

2

Process

Our AI pipeline analyzes your genomic data against 25M+ medical journals.

3

Act

Receive personalized therapy and clinical trial recommendations in under 24 hours.

Start Your Free Trial